Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint–Based Therapy in Patients With Advanced NSCLC

15/4/2021

JAMA Oncology Author Interviews

0:00

15:06

Interview with Charu Aggarwal, MD, and Lova Sun, MD, authors of Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

Altri episodi di "JAMA Oncology Author Interviews"

T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
18/4/2024
19:57
Interview with Roni Shouval, MD, PhD, author of T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. Hosted by Vivek Subbiah, MD. Related Content: T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time
21/3/2024
25:53
Interview with Tobias Janowitz, MD, PhD, and Karen Winkfield, MD, PhD, authors of Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time. Hosted by Vivek Subbiah, MD. Related Content: Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time
Non perdere nemmeno un episodio di “JAMA Oncology Author Interviews”. Iscriviti all'app gratuita GetPodcast.
Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer
29/2/2024
14:26
Interview with José P. Leone, MD, author of Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer. Hosted by Nora L. (Mary) Disis, MD. Related Content: Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer
Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US
4/1/2024
17:31
Interview with Sajid A. Khan, MD, author of Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. Hosted by Mary L. (Nora) Disis, MD. Related Content: Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US
Atezolizumab in Combination With Carboplatin in Metastatic TNBC
14/12/2023
18:18
Interview with Jennifer A. Pietenpol, PhD, Brian D. Lehmann, PhD, and Vandana G. Abramson, MD, authors of Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial. Hosted by Mary L. (Nora) Disis, MD. Related Content: Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer
Shorter-Course Radiotherapy for Prostate Cancer
5/10/2023
15:14
Interview with Daniel E. Spratt, MD, author of Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer. Hosted by Jack West, MD. Related Content: Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer
Sentinel Lymph Node Biopsy vs No Axillary Procedure in Small Node-Negative Breast Cancer
21/9/2023
19:02
Interview with Oreste Davide Gentilini, MD, author of Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial. Hosted by Jack West, MD. Related Content: Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes
A Geospatial Analysis of Disparities in Access to Oncofertility Services
10/8/2023
23:12
Interview with Kara N. Goldman, MD, author of A Geospatial Analysis of Disparities in Access to Oncofertility Services. Hosted by Jack West, MD. Related Content: A Geospatial Analysis of Disparities in Access to Oncofertility Services
Integrated Clinical-Molecular Classification of Colorectal Liver Metastases
20/7/2023
16:29
Interview with Sean P. Pitroda, MD, author of Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial. Hosted by Jack West, MD. Related Content: Integrated Clinical-Molecular Classification of Colorectal Liver Metastases
US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020
29/6/2023
17:16
Interview with Sophia C. Kamran, MD, author of US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020. Hosted by Jack West, MD. Related Content: US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020

Altri episodi

Accedi a tutto il mondo dei podcast con l’app gratuita GetPodcast.

Iscriviti ai tuoi podcast preferiti, ascolta gli episodi offline e ricevi fantastici consigli.

Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint–Based Therapy in Patients With Advanced NSCLC

JAMA Oncology Author Interviews

Altri episodi di "JAMA Oncology Author Interviews"

T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time

Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer

Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

Atezolizumab in Combination With Carboplatin in Metastatic TNBC

Shorter-Course Radiotherapy for Prostate Cancer

Sentinel Lymph Node Biopsy vs No Axillary Procedure in Small Node-Negative Breast Cancer

A Geospatial Analysis of Disparities in Access to Oncofertility Services

Integrated Clinical-Molecular Classification of Colorectal Liver Metastases

US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020